Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
Lab Test

ALL Cytogenetics 2

ALL Cytogenetics 2 is a highly specialized diagnostic panel, used for evaluating patients suspected to have Acute Lymphoblastic Leukemia (ALL), a cancer of the white blood cells. This panel includes karyotyping and Fluorescence In Situ Hybridization (FISH) tests, which are used to examine the chromosomes in a sample of blood or bone marrow. The main focus is on detecting chromosomal abnormalities that are often associated with ALL, specifically BCR-ABL1, TEL-AML1, and MLL rearrangements. These chromosomal changes can be essential in diagnosing ALL, understanding its progression, and making critical treatment decisions.

  • Profile Name: ALL Cytogenetics 2
  • Sample Type: Bone Marrow or Blood
  • Preparations Required: No specific preparations such as fasting are required. However, it is important to inform the doctor about any medications being taken.
  • Report Time: 12 days

What is Acute Lymphoblastic Leukemia (ALL)?

ALL is a type of blood cancer where the bone marrow makes too many lymphocytes, a type of white blood cell. This overproduction of immature cells can hinder the bone marrow's ability to produce healthy blood cells.

Why is the ALL Cytogenetics 2 panel essential?

This panel is essential for the diagnosis and management of ALL. The detection of chromosomal abnormalities provides vital information on the type and severity of leukemia, which can guide treatment strategies.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

The panel provides information on chromosomal structure and abnormalities, such as BCR-ABL1, TEL-AML1, and MLL rearrangements. This information is crucial for diagnosing ALL, determining the subtype, and deciding on the most effective treatment plan.

This test is typically done when a patient shows signs and symptoms suggestive of ALL, such as fatigue, fever, and easy bruising, or when other blood tests indicate abnormal results.

No specific preparation such as fasting is required for this test. However, it’s important to inform the doctor about any medications or supplements being taken, as they might interfere with the results

Normal results would indicate that no abnormal chromosomal changes or rearrangements are present. However, the presence of certain abnormalities can indicate ALL or a specific subtype.

Factors such as the presence of leukemia cells, genetic mutations, and ongoing treatment can affect the results of this test.

The risks are similar to those of a regular blood draw, including pain, bleeding, or infection at the puncture site. If a bone marrow sample is required, there might be additional risks.

The results of this panel can significantly influence treatment decisions. Identifying specific chromosomal abnormalities allows doctors to choose targeted therapies that are more likely to be effective against the particular subtype of ALL.

If there are abnormal values, it’s crucial to consult a hematologist or oncologist who specializes in blood disorders and cancer.

This test is generally done at the time of diagnosis and may be repeated if monitoring for specific genetic changes is necessary during treatment, or if there is a relapse.

FISH is used to detect specific genetic changes and chromosomal rearrangements that are too small to be seen with karyotyping. It helps in identifying specific subtypes of ALL, which can be critical for prognosis and treatment.

Karyotyping is a test that evaluates the number and structure of chromosomes in cells. In ALL, karyotyping is used to find out if there are changes in the chromosomes of cells that might be causing or advancing the leukemia.

While lifestyle and dietary changes may contribute to the overall health of a patient with ALL, they are unlikely to significantly impact the results of the genetic tests or the course of the disease.

Understanding the genetic makeup of Acute Lymphoblastic Leukemia is critical for ensuring the best possible outcome. The ALL Cytogenetics 2 panel is a fundamental component of the diagnostic process and guides the decision-making for treatment strategies. It's important to keep in communication with the doctor and actively participate in the management and treatment plan.

ALL Cytogenetics 2 ( Karyotyping + FISH for BCR-ABL1 + TEL- AML1 + MLL )
₹ 13250 Add to Cart
Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet